Physician profile

Gregory G Lovallo

Urology · Maywood, NJ

NPI 1467515775

$6,272.95

in general payments reported to CMS, 2019-2025

43 companies · $1,323 in 2025

The $1,323 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,819.61

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Royal Biologics, INC. $820.14 2019
Ethicon US, LLC $685.80 2019-2025 Stratafix, Echelon Flex, Surgicel Nu-Knit
Kerecis Limited $601.95 2024-2025 Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose
Procept Biorobotics Corporation $537.16 2019-2025 Aquabeam System
Boston Scientific Corporation $426.40 2019-2023
Astellas Pharma US INC $377.29 2019-2022
Coloplast Corp $373.01 2022-2025
Allergan, INC. $224.83 2019-2021
Laborie Medical Technologies Corp. $167.35 2023-2025 Optilume Bph Drug Coated Balloon Catheter
Edap Technomed INC $158.28 2025
Profound Medical Corp. $144.90 2025 Tulsa-Pro
Urogen Pharma, INC. $136.27 2021-2022
Teleflex LLC $131.81 2025 Barrigel, Urolift
Conmed Corporation $130.39 2022
Tolmar, INC. $115.87 2024-2025 Jatenzo, Eligard
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Olympus America INC. $96.75 2022-2025 Itind System
Janssen Biotech, INC. $92.26 2019-2025 Erleada
Bayer Healthcare Pharmaceuticals INC. $91.51 2019-2025
Urovant Sciences INC $88.09 2021-2022
Biotissue Holdings INC. $64.28 2019
Calyxo, INC. $62.33 2023-2024 Cvac Aspiration System
Myovant Sciences INC. $58.78 2021-2022
Pfizer INC. $57.45 2019-2020
Endo Pharmaceuticals INC. $54.35 2020-2021
Davol INC. $51.37 2024 Channel Drain
Ferring Pharmaceuticals INC. $49.81 2024-2025 Adstiladrin
Azurity Pharmaceuticals, INC. $49.80 2025 Azmiro
Clarus Therapeutics INC. $45.94 2021
Tolmar Pharmaceuticals, INC. $43.56 2019-2022
Medtronic, INC. $42.11 2025 Signia
Dendreon Pharmaceuticals LLC $41.21 2020-2021
Koelis INC. $39.87 2021
Janssen Scientific Affairs, LLC $31.07 2025 Erleada
Astrazeneca Pharmaceuticals LP $29.59 2020-2025 Lynparza
Metuchen Pharmaceuticals $25.50 2019-2020
Organogenesis INC. $22.38 2024
Axonics, INC. $18.59 2022
Sumitomo Pharma America, INC. $18.55 2025 Gemtesa
C. R. Bard, INC. & Subsidiaries $17.87 2020
180 Medical, INC. $17.84 2019
Photocure INC $16.59 2025 Cysview
Avadel Specialty Pharmaceuticals, LLC $14.05 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$600,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gregory G Lovallo

$6,272.95

in general payments reported 2019-2025

Years
2019-2025
Top company
Royal Biologics, INC.
Context
The $1,323 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/292828/gregory-g-lovallo

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.